WO2009078030A1 - Substitut de graisse - Google Patents
Substitut de graisse Download PDFInfo
- Publication number
- WO2009078030A1 WO2009078030A1 PCT/IN2008/000107 IN2008000107W WO2009078030A1 WO 2009078030 A1 WO2009078030 A1 WO 2009078030A1 IN 2008000107 W IN2008000107 W IN 2008000107W WO 2009078030 A1 WO2009078030 A1 WO 2009078030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fat
- omega
- fatty acid
- fat substitute
- substitute
- Prior art date
Links
- 235000013341 fat substitute Nutrition 0.000 title claims abstract description 75
- 239000003778 fat substitute Substances 0.000 title claims abstract description 75
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 65
- 239000000194 fatty acid Substances 0.000 claims abstract description 65
- 229930195729 fatty acid Natural products 0.000 claims abstract description 65
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 61
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 230000021615 conjugation Effects 0.000 claims abstract description 15
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 18
- 150000002482 oligosaccharides Chemical class 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 16
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 12
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 7
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 claims description 6
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 229930003802 tocotrienol Natural products 0.000 claims description 6
- 239000011731 tocotrienol Substances 0.000 claims description 6
- 229940068778 tocotrienols Drugs 0.000 claims description 6
- 235000019148 tocotrienols Nutrition 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 claims description 3
- 239000003075 phytoestrogen Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 125000002640 tocopherol group Chemical class 0.000 claims description 3
- 235000019149 tocopherols Nutrition 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 1
- 230000007407 health benefit Effects 0.000 abstract description 6
- 239000003925 fat Substances 0.000 description 48
- 235000019197 fats Nutrition 0.000 description 43
- 235000013305 food Nutrition 0.000 description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 235000019944 Olestra Nutrition 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 9
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
- 230000037213 diet Effects 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 6
- 235000004626 essential fatty acids Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- -1 gums Polymers 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 235000019882 fat-based fat substitute Nutrition 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000004213 low-fat Nutrition 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000036996 cardiovascular health Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000013367 dietary fats Nutrition 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical class OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 238000001030 gas--liquid chromatography Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940057917 medium chain triglycerides Drugs 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000037063 Thinness Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001593 brown adipocyte Anatomy 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000014105 formulated food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009884 interesterification Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000002646 long chain fatty acid esters Chemical class 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 206010048828 underweight Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
Definitions
- the present invention relates to fat substitutes formed by conjugation of oligosaccharides with a fatty acid. More particularly it relates to fat substitutes formed by conjugation of oligosaccharides with omega-3, omega-6 fatty and omega-9 fatty acids. The present invention further relates to fat substitutes that render synergy to the omega fatty acid content and also impart increased heat stability to omega fatty acids.
- Fats are organic compounds that are made up of carbon, hydrogen, and oxygen. They are a source of energy in foods. Fats belong to a group of substances called lipids. This category of molecules is important for many forms of life, serving both structural and metabolic functions. They are an important part of the diet of most heterotrophs including humans.
- Chemically fats are triesters of glycerol and fatty acids. Fats may be either solid or liquid at normal room temperature, depending on their structure and composition. Fats consist of a wide group of compounds that are generally soluble in organic solvents and largely insoluble in water.
- Vitamins A, D, E and K are fat-soluble, meaning they can only be digested, absorbed, and transported in conjunction with fats.
- Fats are sources of essential fatty acids, an important dietary requirement. They are one of the nutrient categories essential for proper growth, development and maintenance of good health. They are an especially important source of calories for people who are underweight and for infants and toddlers, who have the highest energy needs per kilogram of body weight of any age group. Fat also plays important roles in food preparation and consumption. It gives taste, consistency, stability, and palatability to foods.
- Fat provides our most concentrated form of energy. Its energy content (9 calorie/gram) is over twice as great as carbohydrates and proteins (4 calorie/gram). Fat intake also is linked to several chronic diseases. There is some evidence of a link between high intake of fat and a possible increased risk of certain cancers, such as breast, colon and prostate cancers. There also is a link between high intake of saturated fat and cholesterol and an increased risk of coronary heart disease. Too much fat also increases the chance of becoming obese.
- Fat substitutes have opened the door for a new generation of reduced-fat foods that have the taste and texture of the high-fat foods consumers enjoy, but without unnecessary calories, cholesterol or fat.
- the ideal fat substitute thus recreates all the attributes of fat, while also significantly reducing fat and calorie content.
- carbohydrate-based fat substitutes e.g., cellulose, maltodextrins, gums, starches, fiber and polydextrose.
- Carbohydrates have been used safely for many years as thickeners and stabilizers. These ingredients are also effective fat substitutes in many formulated foods, including heat applications but they are not suitable for frying foods.
- Protein-based fat substitutes have tremendous potential for use in a variety of products, especially frozen and refrigerated products but protein-based fat substitutes too are not suitable for frying foods.
- Simplese is an example of a protein-based fat substitute. Simplese can be used in many different kinds of food. Some of these foods are: ice cream, yogurt, salad dressing, and mayonnaise. But simplese cannot be used to cook foods since heat causes the protein to turn into a form of gel, thereby destroying its creamy quality.
- fat-based fat substitutes actually pass through the body virtually unabsorbed.
- Olestra is an example of fat based fat substitute.
- the olestra molecule is larger than a fat molecule, and is therefore not hydrolyzed by the body's digestive enzymes. It does not get absorbed (zero calories) and leads to anal leakage of oil / fat causing discomfort to consumers (oil stained underwear). Intake of olestra also leads to nutritional deficiencies.
- olestra Since olestra passes through the gastrointestinal tract without being digested or absorbed and is lipophilic, olestra has the potential to cause gastrointestinal effects, such as abdominal cramping and stool softening or loosening, and to reduce absorption of fat-soluble vitamins and nutrients, which partition into olestra when ingested at the same time. Fats normally bind to the fat-soluble vitamins A, D, E, and K in the intestine, and when the body absorbs the fat, these essential vitamins bind to the absorbed fat. Similarly these vitamins also stick to the fake fat, olestra. Instead of being taken up into the body, they are excreted, unused, with it. An excessive amount of olestra-containing foods in the diet thus makes the body deficient in these important vitamins.
- Olestra also deprives the body of an important family of nutrients called carotenoids. These red, yellow and orange pigments give fresh fruits and vegetables their color, and they're also found in green leafy vegetables. A lot of evidence suggests that these nutrients protect the body against heart disease, prostate cancer and degeneration of the macula, the part of the eye that lets humans see fine details like newsprint. In clinical studies, people who ate olestra had reduced carotenoid levels in their blood. The idea behind all these fat substitutes is to reduce a food's fat and calories while maintaining the texture provided by fat. However they often fall short; while most contain fewer calories than fat, they don't withstand the cooking temperatures that natural fats do.
- US 4696916 discloses an intravenous nutrient which contains a fatty acid ester of carbohydrate and water.
- the fatty acid ester of carbohydrate disclosed is a long-chain fatty acid ester of oligosaccharide and the long-chain fatty acid is a member selected from the group consisting of oleic acid, linoleic acid, and linolenic acid.
- the present invention is a fat substitute offering an additional advantage of heat stability of omega fatty acids.
- US 4973489 teaches a fat substitute food composition containing a polysaccharide fatty acid polyester.
- the said patent discloses that the polysaccharide is a polymer of at least three monosaccharides and has at least four fatty acid ester groups, each fatty acid portion having from 4 to 24 carbon atoms.
- the present invention relates to oligosaccharide derivatisation with fatty acids with enhanced heat stability of the omega fatty acids.
- the present inventors have surprisingly found that fat substitutes resulting from the conjugation of oligosaccharides with omega 3, omega 6 and omega 9 fatty acids of natural vegetable have properties similar to those of a naturally occurring fat, are stable at higher temperature, exhibit synergy in the content of the constituent omega fatty acids and also effectively facilitate the absorption of omega fatty acids in the body promoting health benefits.
- the fat substitute of the present invention has properties similar to those of a naturally occurring fat.
- the present inventors have observed that all the drawbacks of the existing fat substitutes have been overcome by the fat substitute of the present invention.
- the present inventors have further observed that consumption of products fried / cooked in the fat substitute of the present invention does not cause anal leakage and consumers feel very light, healthy and free from hyperacidity symptoms.
- the present inventors have also observed that shelf life of the finished formulation with respect to other edible oils is almost 3 times more under similar storage conditions.
- the present invention also describes the best absorption of omega components for optimum health benefits such as lowering LDL, increasing HDL cholesterol, lowering triglycerides and improving overall cardiovascular health and central nervous system health.
- At least one of the preceding objects is met, in whole or in part, by the present invention, in which is provided a fat substitute comprising an oligosaccharide in conjugation with a fatty acid.
- a fat substitute comprising an oligosaccharide in conjugation with a fatty acid.
- a process for the synthesis of a fat substitute comprising the step of stirring a mixture of fatty acids and oligosaccharide in the presence of ⁇ -cyclodextrins for a period of 6-10 hours at 45°C.
- composition of a fat substitute further comprising phytoestrogens, natural tocopherols and tocotrienols.
- a process for the preparation of the composition of the fat substitute comprising the steps of: i. Addition of ascorbyl palmitate, tocopheryl acetate, tocotrienols to the fat substitute of the present invention to obtain the finished product; ii. Treatment of the finished product with activated charcoal and passage through sparkler filter to obtain the final product.
- the fat substitute of the present invention is an ideal fat substitute that replaces the fat in foods on a one-to-one, gram-for-gram basis, imparts increased stability to the constituent omega fatty acids at higher temperature, shows synergy in the omega fatty acid content and simultaneously promotes health benefits by getting absorbed and not causing vitamin deficiency.
- the fat substitute of the present invention is synthesized by the conjugation of omega 3, 6, 9 fatty acids or mixtures thereof with Fructo oligosaccharide (GF2, GF3, and GF4 Links).
- GF2 implies one glucose attached to 2 fructose molecules
- GF3 implies one glucose attached to 3 fructose molecules.
- oligosaccharides of glucose, maltose, galactose, rhamnose can be used for interesterification.
- Fats belong to a group of biological substances called lipids. Lipids are biological chemicals that do not dissolve in water. Fats are esters of the tri-alcohol, glycerol. Therefore, fats are commonly called triglycerides. The structural formula of fats is as under:
- Fat substitutes are macromolecules that physically and chemically resemble triglycerides and mimic the molecular shape of fat— one molecule of glycerol attached to three molecules of fatty acids.
- the glycerol molecule is replaced with the above oligosaccharides and has 6 to 15 fatty acids attached.
- MCT - Medium chain triglycerides can also be included in the above link. Medium chain triglycerides form an integral part of the molecule along with Fatty acid molecules.
- omega fatty acids come from a variety of vegetable oils, such as soybean, corn, palm, coconut, and cottonseed oils.
- Essential fatty acids or EFAs are fatty acids that cannot be constructed within an organism from other components by any known chemical pathways and therefore must be obtained from the diet.
- EFAs There are two families of EFAs: ⁇ -3 (or omega-3 or n-3) and ⁇ -6 (omega-6 or n-6.)
- Omega-3 and omega-6 fatty acids are very important to our everyday life and function.
- Omega-3 and omega-6 fatty acids are critical in the structure of our cell membranes and the development of the nervous system and form the foundation for the synthesis of cell mediators (prostaglandins and leukotrienes). These cell mediators play an important role in human physiology and affect coagulation, inflammation and proliferation of certain cells.
- the two EFA of significance to humans are alpha linolenic acid (ALA) and linoleic acid (LA).
- ALA alpha linolenic acid
- LA linoleic acid
- omega-3 and omega-6 fatty acids which the body can manufacture from the two essential ones
- Non-essential omega-3 fatty acids include DHA (docosahexaenoic acid) and EPA
- Non-essential omega-6 fatty acids include AA (arachidonic acid) and GLA (gamma- linolenic acid) which the body makes from LA (the omega-6 essential fatty acid).
- omega-3 fatty acids Only one of the omega-3 fatty acids is essential (ALA), and a healthy body can make the others (DHA and EPA).
- the fat substitute of the present invention which contains large amounts of omega-3 fatty acids and omega-6 fatty acids is capable of functioning as an ideal fat substitute and also releasing essential fatty acids to the diet due to its structural speciality. Without wishing to be bound by any theory, it is thought that with these many fatty acids in the structure of the fat substitute of the present invention, the digestive enzymes cannot get to the saccharide center in the time it takes for the substance to move through the digestive tract, resulting in slow and consistent release of essential fatty acids in blood stream after getting absorbed in liver. The center is where breakdown of the substance for absorption into the body would take place. As a result of getting absorbed, the fat substitute of the present invention is not zero calories. The calorie value of the fat substitute of the present invention is upto 40% lower than normal oils i.e. about 5.4 calories/g
- omega fatty acids are not stable at high humidity conditions above 60% R.H. and at high temperatures as they get rancid due to oxidation.
- the fat substitute of the present invention is stable upto 300°C.
- the fat substitute of the present invention does not degrade or show lower omega fatty acid contents when used repeatedly for frying foods. Stability and retention of the finished product and the omega fatty acid is excellent at high temperature.
- the fat substitute of the present invention can be reused upto 20 times repeatedly for frying without any degradation or turning rancid. There are no losses of omega 3, 6, 9 in the said process, the fat substitute of the present invention has no trans fats and does not develop any trans fats in processing and repeated use.
- the fat substitute of the present invention can be used in bakery products like cakes, pastries, cookies, etc.
- the fat substitute of the present invention is very stable at all cooking, frying and food processing conditions including retorting, pasteurization and baking.
- the fat substitute of the present invention offers nutritional benefits due to the following reasons:
- omega 3, 6, 9 include all of the benefits of all three types of fatty acid. The amounts and ratios of each fatty acid are balanced to optimal levels of each. Taking an omega 3, 6, 9 supplement is a good way to ensure that the consumer gets essential nutrients for his/her good health. Fructo oligosaccharide is a very strong prebiotic and soluble fiber which improves immunity and cardiovascular health by lowering LDL cholesterol levels naturally, overall the fat substitute of the present invention is healthy as it is composed of FOS, omega fatty acids, phytoestrogens, natural tocopherols and tocotrienols is zero trans fat and cholesterol.
- Finished product is treated with activated charcoal and passed through sparkler filter to obtain the final product.
- the finished product is stable for almost 6 years when stored at normal ambient temperature of 30 0 C.
- the methyl esters are formed using boron trifluoride or methanol and alkali and separated by gas - liquid chromatography using a flame ionization detector. The pattern of methyl esters can be compared with authentic oils for identification. Fatty acid composition prior to conjugation with FOS
- Example 4 A comparison of the data from Example 3 and Example 4 clearly indicates that the conjugation of omega fatty acids with FOS results in an increase in content of omega fatty acid in the finished product i.e. the fat substitute of the present invention. This aspect highlights the synergy in the omega fatty acid content in the fat substitute.
- Example 5 The comparison of data from Example 5 and Example 6 shows the increased oxidative stability of the omega fatty acid due to conjugation with FOS.
- the above chart shows the heat stability of the fat substitute with increasing temperature during the frying of vegetarian food items.
- the above chart shows the frying stability of the fat substitute with repeated usage.
- the above chart shows the heat stability of the fat substitute with increasing temperature during the frying of non - vegetarian food items.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
Abstract
La présente invention concerne un substitut de graisse formé par la conjugaison de fructo-oligosaccharides avec des acides gras oméga. Le substitut de graisse selon la présente invention confère une stabilité thermique à l'acide gras oméga, présente une synergie dans la teneur en acide gras oméga et offre également des avantages pour la santé. La présente invention porte également sur des compositions comprenant le substitut de graisse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2472MU2007 | 2007-12-17 | ||
IN2472/MUM/2007 | 2007-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009078030A1 true WO2009078030A1 (fr) | 2009-06-25 |
Family
ID=39865947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000107 WO2009078030A1 (fr) | 2007-12-17 | 2008-02-25 | Substitut de graisse |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009078030A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160310602A1 (en) * | 2013-12-18 | 2016-10-27 | Centro De Investigacion Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A.C. | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD227137A1 (de) * | 1984-10-03 | 1985-09-11 | Adw Ddr | Verfahren zur herstellung von polyolester-gemischen |
US4614718A (en) * | 1983-08-23 | 1986-09-30 | Dai-Ichio Kogyo Seiyaku Co., Ltd. | Synthesis of sugar or sugar-alcohol fatty acid esters |
JPS62263143A (ja) * | 1986-05-09 | 1987-11-16 | Kao Corp | サイクロデキストリン包接物 |
EP0268974A2 (fr) * | 1986-11-21 | 1988-06-01 | Hoechst Aktiengesellschaft | Méthode de préparation de mélanges de mono- et oligomères d'esters de carbohydrates, les mélanges d'esters de carbohydrates ainsi obtenus et leur utilisation |
US4973489A (en) * | 1987-05-13 | 1990-11-27 | Curtice Burns, Inc. | Polysaccaride fatty acid polyester fat substitutes |
EP0434119A2 (fr) * | 1989-12-21 | 1991-06-26 | Unilever N.V. | Procédé pour raffiner le produit brut de production de polyesters de polyols et acides gras, contenant du savon |
EP0470452A2 (fr) * | 1990-08-09 | 1992-02-12 | Staroil Limited | Procédé de préparation de complexes d'acides gras polyinsaturés à longue chaîne avec des cyclodextrines |
EP0647652A2 (fr) * | 1993-10-05 | 1995-04-12 | Kraft Foods, Inc. | Procédé de préparation de polyesters de saccharides par transestérification |
US6080853A (en) * | 1996-08-08 | 2000-06-27 | The Procter & Gamble Company | Polyol polyester synthesis |
FR2898817A1 (fr) * | 2006-03-23 | 2007-09-28 | Univ Rouen | Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines |
-
2008
- 2008-02-25 WO PCT/IN2008/000107 patent/WO2009078030A1/fr active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614718A (en) * | 1983-08-23 | 1986-09-30 | Dai-Ichio Kogyo Seiyaku Co., Ltd. | Synthesis of sugar or sugar-alcohol fatty acid esters |
DD227137A1 (de) * | 1984-10-03 | 1985-09-11 | Adw Ddr | Verfahren zur herstellung von polyolester-gemischen |
JPS62263143A (ja) * | 1986-05-09 | 1987-11-16 | Kao Corp | サイクロデキストリン包接物 |
EP0268974A2 (fr) * | 1986-11-21 | 1988-06-01 | Hoechst Aktiengesellschaft | Méthode de préparation de mélanges de mono- et oligomères d'esters de carbohydrates, les mélanges d'esters de carbohydrates ainsi obtenus et leur utilisation |
US4973489A (en) * | 1987-05-13 | 1990-11-27 | Curtice Burns, Inc. | Polysaccaride fatty acid polyester fat substitutes |
EP0434119A2 (fr) * | 1989-12-21 | 1991-06-26 | Unilever N.V. | Procédé pour raffiner le produit brut de production de polyesters de polyols et acides gras, contenant du savon |
EP0470452A2 (fr) * | 1990-08-09 | 1992-02-12 | Staroil Limited | Procédé de préparation de complexes d'acides gras polyinsaturés à longue chaîne avec des cyclodextrines |
EP0647652A2 (fr) * | 1993-10-05 | 1995-04-12 | Kraft Foods, Inc. | Procédé de préparation de polyesters de saccharides par transestérification |
US6080853A (en) * | 1996-08-08 | 2000-06-27 | The Procter & Gamble Company | Polyol polyester synthesis |
FR2898817A1 (fr) * | 2006-03-23 | 2007-09-28 | Univ Rouen | Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160310602A1 (en) * | 2013-12-18 | 2016-10-27 | Centro De Investigacion Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A.C. | Bioconjugate molecules with biological and techno-functional activity, method for the production thereof and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7007010B2 (ja) | 脂質含有組成物およびその使用方法 | |
RU2670880C9 (ru) | Источник жиров растительного происхождения | |
US20060088574A1 (en) | Nutritional supplements | |
EP3135119A1 (fr) | Composition de boisson pour suppression de gain de poids | |
CN103380827B (zh) | 一种预防肥胖性脂肪肝的油脂组合物及其制备方法 | |
CN101720822A (zh) | 一种脂肪酸组分平衡并含有活性成分的中老年型营养调和油 | |
JP2011518223A5 (fr) | ||
CN101810226A (zh) | 一种脂肪酸组分平衡并含有多种活性成分的儿童型营养调和油 | |
AU2007286643B2 (en) | Cold formed cereal bar fortified with omega-3 fatty acids and processes for making same | |
BRPI0612917A2 (pt) | produto nutricional composto seu uso e processo de fabricação | |
McClements | Ultraprocessed plant‐based foods: Designing the next generation of healthy and sustainable alternatives to animal‐based foods | |
EA003833B1 (ru) | Пищевая композиция, содержащая эмульсию триглицеридных масел типа "масло-в-воде" и применение эмульсии в качестве пищевого продукта или для приготовления пищевых и фармацевтических композиций | |
Arslaner et al. | Functional ice cream technology | |
WO2013147138A1 (fr) | Composition d'huile et de graisse | |
CN107683909A (zh) | 生酮饮食专用调和油 | |
KR102472964B1 (ko) | 겔상 유화 식품 | |
Crosby | Cook, taste, learn: How the evolution of science transformed the art of cooking | |
WO2009078030A1 (fr) | Substitut de graisse | |
CN1568768A (zh) | 玉米淀粉脂肪代用品的生产方法 | |
CN101530137A (zh) | 一种新型米饭食用油及其制备方法 | |
Casper | Diet and mental health: an up-to-date analysis | |
EP2053922A2 (fr) | Barre de fruits cuite renforcée d'acides gras oméga-3 et ses procédés de fabrication | |
US20090087513A1 (en) | Fiber and fatty acid composition and method of making same | |
WO2021200698A1 (fr) | Composition pour améliorer la convivialité et/ou la capacité empathique | |
Greenly | A nutrition primer: Fat and cholesterol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08720135 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08720135 Country of ref document: EP Kind code of ref document: A1 |